Profile
AFIB ABT BSX-PA BSX SYK MDT
Company Name Acutus Medical, Inc. Abbott Laboratories Boston Scientific Corporation Boston Scientific Corporation Stryker Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $8.97K $216.98B $175.45B $149.02B $141.06B $116.69B
Employees 0.09K 114.00K 45.00K 53.00K 53.00K 95.00K
CEO Takeo Mukai Robert B. Ford Michael F. Mahoney Michael F. Mahoney Kevin A. Lobo Geoffrey Straub Martha
Ratings
AFIB ABT BSX-PA BSX SYK MDT
Quant Rating Score 2 4 1 3 3
Quant Rating Sell Buy Strong Sell Neutral Neutral
Trading
AFIB ABT BSX-PA BSX SYK MDT
Last Close $0.0003 $124.67 $122.18 $100.57 $368.98 $90.97
High 52 $0.16 $140.22 $122.18 $108.14 $403.53 $98.43
Low 52 - $111.1 $122.18 $83.62 $337.28 $79.61
Price vs. 52 Week High -99.81 % -11.09 % 0 % -7 % -8.56 % -7.58 %
Price vs. 52 Week Low 0 % 12.21 % 0 % 20.27 % 9.4 % 14.27 %
Total Return
AFIB ABT BSX-PA BSX SYK MDT
1 Month Return -40 % -6.59 % 0 % 4.92 % 1.31 % -4.05 %
3 Month Return -40 % -1.2 % 0 % -4.15 % -6.4 % 0.81 %
6 Month Return -99.23 % -4.74 % 0 % -2.54 % -1.34 % 8.87 %
9 Month Return -99.5 % -2.55 % 0 % -1.75 % -5.7 % 0.17 %
YTD Return -99.4 % 10.22 % 0 % 12.6 % 2.48 % 13.88 %
1 Year Return -99.79 % 9.97 % 0 % 19.7 % 3.56 % 1.93 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AFIB ABT BSX-PA BSX SYK MDT
Dividend Yield Percentage (TTM) - 1.89 % - - 0.91 % 3.1 %
Dividend Paid and Capex Coverage Ration (TTM) -2104.43 % 1.45 % 4.3 % 4.3 % 2.39 % 1.31 %
Dividend Per Share (TTM) - 2.36 % - - 3.36 % 2.82 %
Payout Ratio (TTM) - 28.42 % 0.82 % 0.82 % 42.87 % 77.26 %
Growth
AFIB ABT BSX-PA BSX SYK MDT
Asset Growth -46.91 % 11.2 % 12.12 % 12.12 % 1.89 %
Gross Profit Growth 132.29 % 6.43 % 16.26 % 16.26 % 3.58 %
Revenue Growth 181.37 % 4.59 % 17.61 % 17.61 % 3.62 %
Revenue 3 Year 12.39 % -0.18 % 36.16 % 36.16 % 10.52 %
Revenue 5 Year 554.95 % 34.24 % 47.52 % 47.52 % 20.96 %
Revenue 10 Year 426.82 % 80.43 % 104.22 % 104.22 % 41.05 %
EBIT Growth 119.7 % 3.45 % 18.25 % 18.25 % 14.42 %
Net Income Growth 88.31 % 134.18 % 16.38 % 16.38 % 26.82 %
Net Income 3 Yeari Growth Per Share 92.55 % 94.27 % 72.31 % 72.31 % -3.39 %
Net Income 5 Yeari Growth Per Share 92.63 % 271.11 % -62.7 % -62.7 % 1.52 %
Net Income 10 Yeari Growth Per Share 88.72 % 410.99 % 1502.13 % 1502.13 % 48.51 %
Operating Income Growth 99.6 % 6.06 % 20.82 % 20.82 % 15.77 %
Operating Cash Flow Growth (CFG) 49.84 % 17.86 % 37.24 % 37.24 % 3.79 %
Operating 3 Year CFG 69.43 % -16.72 % 77.55 % 77.55 % 0.13 %
Operating 5 Year CFG 47.89 % 42.4 % 76.92 % 76.92 % 1.55 %
Operating 10 Year CFG 46.94 % 102.79 % 143.61 % 143.61 % 22.45 %
EPS Growth 88.6 % 132.42 % 16.61 % 16.61 % 31.05 %
EPS Diluted Growth 88.6 % 133.64 % 16.52 % 16.52 % 30.8 %
Book Value Per Share -1188.96 % 23.54 % 11.25 % 11.25 % -1.16 %
Share Holder 3 Year Equity Growth Per Share -110.55 % 36.46 % 26.58 % 26.58 % -4.58 %
Share Holder 5 Year Equity Growth Per Share 95.27 % 56.53 % 48.35 % 48.35 % -1.29 %
Share Holder 10 Year Equity Growth Per Share 95.02 % 92.83 % 186.31 % 186.31 % -23.12 %
Dividend Per Share Growth - 8.02 % -100 % -100 % 1.11 %
Dividend 3 Year Growth Per Share - 22.8 % -100 % -100 % 10.78 %
Dividend 5 Year Growth Per Share - 72.53 % - - 29.33 %
Dividend 10 Year Growth Per Share - 148.92 % - - 128.74 %
Debt Growth -7.06 % -3.77 % 17.44 % 17.44 % 13.95 %
Free Cash Flow Growth 49.84 % 25.54 % 55.31 % 55.31 % -0.29 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 25 Apr 2025
Profitability
AFIB ABT BSX-PA BSX SYK MDT
Gross Profit Margin TTM 6.25 % 52.79 % 65.05 % 65.05 % 62.19 % 63.44 %
Return on Assets TTM -27.67 % 16.64 % 6.71 % 6.71 % 6.3 % 5.12 %
Return on Equity TTM 89.08 % 29.93 % 12.8 % 12.8 % 14.08 % 9.62 %
Return on Capital Employed TTM 3.2 % 10.7 % 9.22 % 9.22 % 13.86 % 7.71 %
Net Income Per EBT TTM 319.51 % 176.99 % 85.26 % 85.26 % 87.08 % 82.32 %
EBT Per Ebit TTM -478.96 % 104.64 % 97.5 % 97.5 % 61.93 % 92.49 %
EBIT Per Revenue TTM 3.13 % 17.51 % 17.33 % 17.33 % 22.72 % 17.9 %
Cash Flow To Debt Ratio TTM -41.19 % 67.25 % 35.63 % 35.63 % 27.83 % 24.98 %
Receivables Turnover TTM 2.1 4.21 6.87 6.87 6.08 5.46
Payables Turnover TTM 12.14 4.73 7.03 7.03 6.25 4.89
Inventory Turnover TTM 8.65 2.93 2.36 2.36 1.7 -33.52
Fixed Asset Turnover TTM 555.51 % 378.32 % 489.63 % 489.63 % 560.03 % -6785.71 %
Asset Turnover TTM 57.71 % 51.32 % 46.56 % 46.56 % 51.41 % 37.59 %
Operating Cash Flow Per Share TTM -0.49 5.19 2.89 2.89 12.47 5.58
Free Cash Flow Per Share TTM -0.5 3.89 2.23 2.23 10.53 4.14
Cash Per Share TTM 47.09 % 418.4 % 36.04 % 36.04 % 644.69 % 633.66 %
Operating Cash Flow Sales Ratio TTM -89.11 % 20.96 % 22.14 % 22.14 % 20.01 % 20.89 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.05 % 74.97 % 77.27 % 77.27 % 84.43 % 74.21 %
Cash Flow Coverage Ratios TTM -41.19 % 67.25 % 35.63 % 35.63 % 27.83 % 24.98 %
Price To Free Cash Flows Ratio TTM - 32.03 44.89 45.01 35.06 22
Price To Operating Cash Flows Ratio TTM - 24.01 34.68 34.78 29.59 16.32
Price Cash Flow Ratio TTM - 24.01 34.68 34.78 29.59 16.32
Income Statement (TTM)
AFIB ABT BSX-PA BSX SYK MDT
Revenue $0.02B $41.95B $16.75B $16.75B $22.6B $33.54B
Gross Profit $0B $21.33B $10.27B $10.27B $13.98B $21.91B
Gross Profit Ratio 5.03% 50.83% 61.31% 61.31% 61.87% 65.32%
EBITDA $0B $10.83B $3.94B $3.94B $4.94B $9.22B
Net Income $-0.01B $13.4B $1.85B $1.85B $2.99B $4.66B
EPS Diluted -0.32 7.64 1.25 1.25 7.76 3.61
Balance Sheet (MRQ)
AFIB ABT BSX-PA BSX SYK MDT
Long Term Debt $0.03B $13.52B $9.37B $9.37B $12.57B $25.64B
Total Liabilities $0.04B $33.51B $17.39B $17.39B $22.34B $43.42B
Total Equity $-0.01B $47.9B $22B $22B $20.63B $48.26B
Total Investments $0B $1.24B $0.56B $0.56B $0.88B $6.75B
Total Debt $0.04B $15.28B $11.15B $11.15B $14.12B $28.52B
Total Assets $0.03B $81.41B $39.4B $39.4B $42.97B $91.68B
Cash Flow Statement (TTM)
AFIB ABT BSX-PA BSX SYK MDT
Net Income $-0B $13.4B $1.85B $1.85B $2.99B $4.69B
Inventory $0B $-0.06B $-0.23B $-0.23B $-0.21B $-0.29B
Dividends Paid $0B $-3.84B $0B $0B $-1.22B $-3.59B
Operating Cash Flow $-0.03B $8.56B $3.44B $3.44B $4.24B $7.04B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.79B $-0.76B $-1.86B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 123.61
ADGM Adagio Medical Holdings, Inc. 1.14
AEMD Aethlon Medical, Inc. 5.19
AHCO AdaptHealth Corp. 8.93
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 137.96
ALUR Allurion Technologies Inc. 1.83
AMIX Autonomix Medical, Inc. Common Stock 1.03
ANIK Anika Therapeutics, Inc. 9.765
AORT Artivion, Inc. 45.4
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 3.03
ARAY Accuray Incorporated 1.42
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 18.97
AVNS Avanos Medical, Inc. 11.085
AVR Anteris Technologies Global Corp. Common Stock 4.49
AXDX Accelerate Diagnostics, Inc. 0.034
AXGN AxoGen, Inc. 22.205
ETFs With Exposure to AFIB
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 335.49
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00002 148.985
VXF Vanguard Extended Market Index Fund 0 211.82
VFLQ Vanguard U.S. Liquidity Factor ETF 0.04 99.7611
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 158.89
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 158.9
JKK iShares Morningstar Small-Cap Growth ETF 0 307.42
JKJ iShares Morningstar Small-Cap ETF 0 231.193
VEMPX Vanguard Extended Market Index InstlPlus 0 392.11
Unlock